Perth partnership targets childhood blindness and $1 billion market, page-22

My guess its hard put an estimate on 'how much' because we appear to be in a new paradigm. the eye in a petri, 3D organiods, testing on the DNA of the actual clinical trial participants before the clinical trial and LEI's database of clinical trial participants all means its likely to be significantly more efficient / cost effective process than normal. how much more...who knows? how much saving is fast-tracking from phase1 to pivotal clinical trials in potentially 3 months worth? the CEO / Mgmt will have done their sums and I suspect the amount raised is exactly what they need - no more - no less. now for execution...